Cedars-Sinai Health Sciences University investigators have identified molecular mechanisms that drive inflammation in alcohol-associated liver disease. Their preclinical discoveries could one day provide targets for therapies to treat the potentially fatal condition.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗